🟢 Kailera Therapeutics is trading 4.59% up in after-hours trading following a 6.55% regular-session decline

Kailera Therapeutics is trading 4.59% up now at $12.54 after closing September 21, 2026 at $11.99, following a 6.55% regular-session decline.

• No verified company-specific catalyst dated September 21 was identified.
• The latest official announcement covers upcoming September investor conferences, including Bernstein’s Healthcare Forum—not a new earnings release or material corporate development.
• The broader market was strongly higher, but the regular-session decline and rebound do not establish a direct market-driven explanation; the after-hours move remains unexplained.